Ask AI
ProCE Banner Activity

The APP’s Guide to Patient-Centered BTK Inhibitor Therapy in Lymphoma

Clinical Thought

This expert commentary allows the learner to gain insights into selecting the most appropriate BTK inhibitor for patients with CLL and MCL.

Released: November 10, 2025

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from BeOne Medicines.

BeOne Medicines

Partners

Clinical Care Options, LLC

ProCE Banner

Faculty Disclosure

Primary Author

Emily Patterson, AGACNP-BC, has no relevant financial relationships to disclose.